nodes	percent_of_prediction	percent_of_DWPC	metapath
Ixabepilone—Microtubule Inhibition—Paclitaxel—kidney cancer	0.535	1	CiPCiCtD
Ixabepilone—TUBB2B—Paclitaxel—kidney cancer	0.0152	0.042	CbGbCtD
Ixabepilone—TUBB8—Paclitaxel—kidney cancer	0.0152	0.042	CbGbCtD
Ixabepilone—TUBB6—Paclitaxel—kidney cancer	0.0152	0.042	CbGbCtD
Ixabepilone—TUBB3—Paclitaxel—kidney cancer	0.0152	0.042	CbGbCtD
Ixabepilone—TUBB4A—Paclitaxel—kidney cancer	0.0152	0.042	CbGbCtD
Ixabepilone—TUBB2A—Paclitaxel—kidney cancer	0.0152	0.042	CbGbCtD
Ixabepilone—TUBB2B—Vinblastine—kidney cancer	0.0134	0.0368	CbGbCtD
Ixabepilone—TUBB6—Vinblastine—kidney cancer	0.0134	0.0368	CbGbCtD
Ixabepilone—TUBB4A—Vinblastine—kidney cancer	0.0134	0.0368	CbGbCtD
Ixabepilone—TUBB2A—Vinblastine—kidney cancer	0.0134	0.0368	CbGbCtD
Ixabepilone—TUBB3—Vinblastine—kidney cancer	0.0134	0.0368	CbGbCtD
Ixabepilone—TUBB8—Vinblastine—kidney cancer	0.0134	0.0368	CbGbCtD
Ixabepilone—TUBB4A—Vincristine—kidney cancer	0.0131	0.0362	CbGbCtD
Ixabepilone—TUBB2B—Vincristine—kidney cancer	0.0131	0.0362	CbGbCtD
Ixabepilone—TUBB8—Vincristine—kidney cancer	0.0131	0.0362	CbGbCtD
Ixabepilone—TUBB6—Vincristine—kidney cancer	0.0131	0.0362	CbGbCtD
Ixabepilone—TUBB2A—Vincristine—kidney cancer	0.0131	0.0362	CbGbCtD
Ixabepilone—TUBB3—Vincristine—kidney cancer	0.0131	0.0362	CbGbCtD
Ixabepilone—TUBB4B—Paclitaxel—kidney cancer	0.0127	0.0351	CbGbCtD
Ixabepilone—TUBB1—Paclitaxel—kidney cancer	0.0127	0.0351	CbGbCtD
Ixabepilone—TUBB—Paclitaxel—kidney cancer	0.0127	0.0351	CbGbCtD
Ixabepilone—TUBB—Vinblastine—kidney cancer	0.0112	0.0308	CbGbCtD
Ixabepilone—TUBB1—Vinblastine—kidney cancer	0.0112	0.0308	CbGbCtD
Ixabepilone—TUBB4B—Vinblastine—kidney cancer	0.0112	0.0308	CbGbCtD
Ixabepilone—TUBB—Vincristine—kidney cancer	0.011	0.0303	CbGbCtD
Ixabepilone—TUBB4B—Vincristine—kidney cancer	0.011	0.0303	CbGbCtD
Ixabepilone—TUBB1—Vincristine—kidney cancer	0.011	0.0303	CbGbCtD
Ixabepilone—CYP3A4—Everolimus—kidney cancer	0.00234	0.00646	CbGbCtD
Ixabepilone—CYP3A4—Temsirolimus—kidney cancer	0.00158	0.00436	CbGbCtD
Ixabepilone—CYP3A4—Pazopanib—kidney cancer	0.000832	0.00229	CbGbCtD
Ixabepilone—CYP3A4—urine—kidney cancer	0.000618	0.0533	CbGeAlD
Ixabepilone—CYP3A4—Erlotinib—kidney cancer	0.000594	0.00163	CbGbCtD
Ixabepilone—CYP3A4—Paclitaxel—kidney cancer	0.000543	0.0015	CbGbCtD
Ixabepilone—TUBB6—Zalcitabine—Gemcitabine—kidney cancer	0.00053	0.582	CbGdCrCtD
Ixabepilone—TUBB2B—nephron tubule—kidney cancer	0.000501	0.0433	CbGeAlD
Ixabepilone—CYP3A4—Sorafenib—kidney cancer	0.000483	0.00133	CbGbCtD
Ixabepilone—CYP3A4—Vinblastine—kidney cancer	0.000477	0.00131	CbGbCtD
Ixabepilone—TUBB—nephron tubule—kidney cancer	0.000474	0.041	CbGeAlD
Ixabepilone—TUBB2A—nephron tubule—kidney cancer	0.000472	0.0407	CbGeAlD
Ixabepilone—TUBB4A—renal system—kidney cancer	0.000472	0.0407	CbGeAlD
Ixabepilone—CYP3A4—Vincristine—kidney cancer	0.000469	0.00129	CbGbCtD
Ixabepilone—TUBB6—nephron tubule—kidney cancer	0.000465	0.0402	CbGeAlD
Ixabepilone—TUBB4A—kidney—kidney cancer	0.000456	0.0394	CbGeAlD
Ixabepilone—TUBB2B—renal system—kidney cancer	0.000456	0.0393	CbGeAlD
Ixabepilone—TUBB2B—cortex of kidney—kidney cancer	0.000429	0.037	CbGeAlD
Ixabepilone—TUBB6—renal system—kidney cancer	0.000423	0.0365	CbGeAlD
Ixabepilone—TUBB4A—gonad—kidney cancer	0.000423	0.0365	CbGeAlD
Ixabepilone—TUBB6—kidney—kidney cancer	0.000409	0.0353	CbGeAlD
Ixabepilone—TUBB2B—gonad—kidney cancer	0.000409	0.0353	CbGeAlD
Ixabepilone—TUBB2B—cardiac atrium—kidney cancer	0.000408	0.0352	CbGeAlD
Ixabepilone—TUBB—cortex of kidney—kidney cancer	0.000406	0.0351	CbGeAlD
Ixabepilone—TUBB4B—nephron tubule—kidney cancer	0.000405	0.0349	CbGeAlD
Ixabepilone—TUBB2A—cortex of kidney—kidney cancer	0.000404	0.0349	CbGeAlD
Ixabepilone—TUBB6—cortex of kidney—kidney cancer	0.000398	0.0344	CbGeAlD
Ixabepilone—CYP3A4—Sunitinib—kidney cancer	0.000391	0.00108	CbGbCtD
Ixabepilone—TUBB—cardiac atrium—kidney cancer	0.000386	0.0333	CbGeAlD
Ixabepilone—TUBB2A—cardiac atrium—kidney cancer	0.000384	0.0332	CbGeAlD
Ixabepilone—TUBB6—gonad—kidney cancer	0.000379	0.0328	CbGeAlD
Ixabepilone—TUBB6—cardiac atrium—kidney cancer	0.000379	0.0327	CbGeAlD
Ixabepilone—TUBB4B—renal system—kidney cancer	0.000368	0.0318	CbGeAlD
Ixabepilone—TUBB4B—kidney—kidney cancer	0.000356	0.0307	CbGeAlD
Ixabepilone—TUBB4B—cortex of kidney—kidney cancer	0.000346	0.0299	CbGeAlD
Ixabepilone—TUBB4B—gonad—kidney cancer	0.00033	0.0285	CbGeAlD
Ixabepilone—TUBB4B—cardiac atrium—kidney cancer	0.000329	0.0284	CbGeAlD
Ixabepilone—CYP3A4—Doxorubicin—kidney cancer	0.000293	0.000807	CbGbCtD
Ixabepilone—TUBB—Azacitidine—Gemcitabine—kidney cancer	0.00027	0.296	CbGdCrCtD
Ixabepilone—CYP3A4—renal system—kidney cancer	0.000151	0.013	CbGeAlD
Ixabepilone—CYP3A4—kidney—kidney cancer	0.000146	0.0126	CbGeAlD
Ixabepilone—TUBB6—Azacitidine—Gemcitabine—kidney cancer	0.000111	0.122	CbGdCrCtD
Ixabepilone—CYP3A4—Estrogen metabolism—GSTM1—kidney cancer	3.6e-05	0.00258	CbGpPWpGaD
Ixabepilone—TUBB1—Transmembrane transport of small molecules—SLC5A3—kidney cancer	3.6e-05	0.00258	CbGpPWpGaD
Ixabepilone—TUBB1—Transmembrane transport of small molecules—ATP7B—kidney cancer	3.6e-05	0.00258	CbGpPWpGaD
Ixabepilone—TUBB1—Transmembrane transport of small molecules—ANXA2—kidney cancer	3.6e-05	0.00258	CbGpPWpGaD
Ixabepilone—TUBB2A—Metabolism of proteins—ST3GAL2—kidney cancer	3.57e-05	0.00256	CbGpPWpGaD
Ixabepilone—TUBB1—Metabolism of proteins—ST3GAL2—kidney cancer	3.49e-05	0.0025	CbGpPWpGaD
Ixabepilone—TUBB2A—Metabolism of proteins—EEF2—kidney cancer	3.49e-05	0.0025	CbGpPWpGaD
Ixabepilone—CYP3A4—Estrogen metabolism—CYP1A1—kidney cancer	3.41e-05	0.00244	CbGpPWpGaD
Ixabepilone—TUBB1—Metabolism of proteins—EEF2—kidney cancer	3.41e-05	0.00244	CbGpPWpGaD
Ixabepilone—TUBB4A—Metabolism of proteins—MUC4—kidney cancer	3.29e-05	0.00236	CbGpPWpGaD
Ixabepilone—CYP3A4—Irinotecan Pathway—APC—kidney cancer	3.27e-05	0.00234	CbGpPWpGaD
Ixabepilone—TUBB4A—Transmembrane transport of small molecules—ANXA2—kidney cancer	3.23e-05	0.00231	CbGpPWpGaD
Ixabepilone—TUBB4A—Transmembrane transport of small molecules—SLC5A3—kidney cancer	3.23e-05	0.00231	CbGpPWpGaD
Ixabepilone—TUBB4A—Transmembrane transport of small molecules—ATP7B—kidney cancer	3.23e-05	0.00231	CbGpPWpGaD
Ixabepilone—Hypersensitivity—Sorafenib—kidney cancer	3.15e-05	0.000416	CcSEcCtD
Ixabepilone—Insomnia—Vincristine—kidney cancer	3.14e-05	0.000416	CcSEcCtD
Ixabepilone—Anorexia—Gemcitabine—kidney cancer	3.14e-05	0.000415	CcSEcCtD
Ixabepilone—Vomiting—Vinblastine—kidney cancer	3.14e-05	0.000415	CcSEcCtD
Ixabepilone—Dizziness—Erlotinib—kidney cancer	3.14e-05	0.000415	CcSEcCtD
Ixabepilone—CYP3A4—Xenobiotics—CYP1A1—kidney cancer	3.14e-05	0.00225	CbGpPWpGaD
Ixabepilone—TUBB4A—Metabolism of proteins—ST3GAL2—kidney cancer	3.13e-05	0.00224	CbGpPWpGaD
Ixabepilone—Connective tissue disorder—Capecitabine—kidney cancer	3.13e-05	0.000414	CcSEcCtD
Ixabepilone—Vomiting—Everolimus—kidney cancer	3.13e-05	0.000413	CcSEcCtD
Ixabepilone—Anaemia—Paclitaxel—kidney cancer	3.13e-05	0.000413	CcSEcCtD
Ixabepilone—Urethral disorder—Capecitabine—kidney cancer	3.12e-05	0.000413	CcSEcCtD
Ixabepilone—Paraesthesia—Vincristine—kidney cancer	3.12e-05	0.000413	CcSEcCtD
Ixabepilone—Rash—Everolimus—kidney cancer	3.1e-05	0.00041	CcSEcCtD
Ixabepilone—Dermatitis—Everolimus—kidney cancer	3.1e-05	0.00041	CcSEcCtD
Ixabepilone—Headache—Vinblastine—kidney cancer	3.09e-05	0.000409	CcSEcCtD
Ixabepilone—Headache—Everolimus—kidney cancer	3.08e-05	0.000407	CcSEcCtD
Ixabepilone—Hypotension—Gemcitabine—kidney cancer	3.08e-05	0.000407	CcSEcCtD
Ixabepilone—Body temperature increased—Dactinomycin—kidney cancer	3.07e-05	0.000406	CcSEcCtD
Ixabepilone—Abdominal pain—Dactinomycin—kidney cancer	3.07e-05	0.000406	CcSEcCtD
Ixabepilone—Asthenia—Sorafenib—kidney cancer	3.06e-05	0.000405	CcSEcCtD
Ixabepilone—TUBB4A—Metabolism of proteins—EEF2—kidney cancer	3.06e-05	0.00219	CbGpPWpGaD
Ixabepilone—Syncope—Paclitaxel—kidney cancer	3.03e-05	0.000401	CcSEcCtD
Ixabepilone—Lethargy—Doxorubicin—kidney cancer	3.03e-05	0.000401	CcSEcCtD
Ixabepilone—Leukopenia—Paclitaxel—kidney cancer	3.03e-05	0.0004	CcSEcCtD
Ixabepilone—Hypersensitivity—Sunitinib—kidney cancer	3.03e-05	0.0004	CcSEcCtD
Ixabepilone—Decreased appetite—Vincristine—kidney cancer	3.02e-05	0.000399	CcSEcCtD
Ixabepilone—Pruritus—Sorafenib—kidney cancer	3.02e-05	0.000399	CcSEcCtD
Ixabepilone—Vomiting—Erlotinib—kidney cancer	3.02e-05	0.000399	CcSEcCtD
Ixabepilone—CYP3A4—Tamoxifen metabolism—CYP1A1—kidney cancer	3.02e-05	0.00216	CbGpPWpGaD
Ixabepilone—Erythema multiforme—Capecitabine—kidney cancer	3.01e-05	0.000398	CcSEcCtD
Ixabepilone—TUBB4B—Metabolism of proteins—MUC4—kidney cancer	3.01e-05	0.00216	CbGpPWpGaD
Ixabepilone—Musculoskeletal discomfort—Gemcitabine—kidney cancer	3e-05	0.000397	CcSEcCtD
Ixabepilone—Gastrointestinal disorder—Vincristine—kidney cancer	3e-05	0.000397	CcSEcCtD
Ixabepilone—Fatigue—Vincristine—kidney cancer	3e-05	0.000396	CcSEcCtD
Ixabepilone—Rash—Erlotinib—kidney cancer	2.99e-05	0.000396	CcSEcCtD
Ixabepilone—Dermatitis—Erlotinib—kidney cancer	2.99e-05	0.000395	CcSEcCtD
Ixabepilone—Hyponatraemia—Doxorubicin—kidney cancer	2.98e-05	0.000394	CcSEcCtD
Ixabepilone—Insomnia—Gemcitabine—kidney cancer	2.98e-05	0.000394	CcSEcCtD
Ixabepilone—Eye disorder—Capecitabine—kidney cancer	2.98e-05	0.000394	CcSEcCtD
Ixabepilone—CYP3A4—Phase 1 - Functionalization of compounds—ALDH1A1—kidney cancer	2.98e-05	0.00213	CbGpPWpGaD
Ixabepilone—Headache—Erlotinib—kidney cancer	2.97e-05	0.000393	CcSEcCtD
Ixabepilone—Loss of consciousness—Paclitaxel—kidney cancer	2.97e-05	0.000393	CcSEcCtD
Ixabepilone—Pain—Vincristine—kidney cancer	2.97e-05	0.000393	CcSEcCtD
Ixabepilone—Constipation—Vincristine—kidney cancer	2.97e-05	0.000393	CcSEcCtD
Ixabepilone—Gastrointestinal haemorrhage—Doxorubicin—kidney cancer	2.97e-05	0.000393	CcSEcCtD
Ixabepilone—Paraesthesia—Gemcitabine—kidney cancer	2.96e-05	0.000391	CcSEcCtD
Ixabepilone—Cardiac disorder—Capecitabine—kidney cancer	2.96e-05	0.000391	CcSEcCtD
Ixabepilone—TUBB4B—Transmembrane transport of small molecules—SLC5A3—kidney cancer	2.96e-05	0.00212	CbGpPWpGaD
Ixabepilone—TUBB4B—Transmembrane transport of small molecules—ATP7B—kidney cancer	2.96e-05	0.00212	CbGpPWpGaD
Ixabepilone—TUBB4B—Transmembrane transport of small molecules—ANXA2—kidney cancer	2.96e-05	0.00212	CbGpPWpGaD
Ixabepilone—Cough—Paclitaxel—kidney cancer	2.95e-05	0.00039	CcSEcCtD
Ixabepilone—Asthenia—Sunitinib—kidney cancer	2.95e-05	0.00039	CcSEcCtD
Ixabepilone—Dyspnoea—Gemcitabine—kidney cancer	2.94e-05	0.000389	CcSEcCtD
Ixabepilone—Nausea—Vinblastine—kidney cancer	2.93e-05	0.000388	CcSEcCtD
Ixabepilone—Nausea—Everolimus—kidney cancer	2.92e-05	0.000386	CcSEcCtD
Ixabepilone—Diarrhoea—Sorafenib—kidney cancer	2.92e-05	0.000386	CcSEcCtD
Ixabepilone—Pruritus—Sunitinib—kidney cancer	2.91e-05	0.000384	CcSEcCtD
Ixabepilone—Angiopathy—Capecitabine—kidney cancer	2.89e-05	0.000382	CcSEcCtD
Ixabepilone—CYP3A4—Biological oxidations—ACY1—kidney cancer	2.88e-05	0.00207	CbGpPWpGaD
Ixabepilone—Immune system disorder—Capecitabine—kidney cancer	2.88e-05	0.000381	CcSEcCtD
Ixabepilone—Arthralgia—Paclitaxel—kidney cancer	2.88e-05	0.000381	CcSEcCtD
Ixabepilone—Myalgia—Paclitaxel—kidney cancer	2.88e-05	0.000381	CcSEcCtD
Ixabepilone—Chest pain—Paclitaxel—kidney cancer	2.88e-05	0.000381	CcSEcCtD
Ixabepilone—Mediastinal disorder—Capecitabine—kidney cancer	2.87e-05	0.00038	CcSEcCtD
Ixabepilone—TUBB4B—Metabolism of proteins—ST3GAL2—kidney cancer	2.87e-05	0.00205	CbGpPWpGaD
Ixabepilone—Decreased appetite—Gemcitabine—kidney cancer	2.87e-05	0.000379	CcSEcCtD
Ixabepilone—Hypersensitivity—Dactinomycin—kidney cancer	2.87e-05	0.000379	CcSEcCtD
Ixabepilone—Chills—Capecitabine—kidney cancer	2.86e-05	0.000378	CcSEcCtD
Ixabepilone—Unspecified disorder of skin and subcutaneous tissue—Paclitaxel—kidney cancer	2.86e-05	0.000378	CcSEcCtD
Ixabepilone—TUBB2B—Metabolism of proteins—MME—kidney cancer	2.86e-05	0.00205	CbGpPWpGaD
Ixabepilone—TUBB6—Metabolism of proteins—MME—kidney cancer	2.86e-05	0.00205	CbGpPWpGaD
Ixabepilone—Gastrointestinal disorder—Gemcitabine—kidney cancer	2.85e-05	0.000376	CcSEcCtD
Ixabepilone—Fatigue—Gemcitabine—kidney cancer	2.84e-05	0.000376	CcSEcCtD
Ixabepilone—Gastrointestinal pain—Vincristine—kidney cancer	2.84e-05	0.000376	CcSEcCtD
Ixabepilone—Dizziness—Sorafenib—kidney cancer	2.82e-05	0.000373	CcSEcCtD
Ixabepilone—Constipation—Gemcitabine—kidney cancer	2.82e-05	0.000373	CcSEcCtD
Ixabepilone—Pain—Gemcitabine—kidney cancer	2.82e-05	0.000373	CcSEcCtD
Ixabepilone—Nausea—Erlotinib—kidney cancer	2.82e-05	0.000373	CcSEcCtD
Ixabepilone—Alopecia—Capecitabine—kidney cancer	2.82e-05	0.000372	CcSEcCtD
Ixabepilone—Diarrhoea—Sunitinib—kidney cancer	2.81e-05	0.000372	CcSEcCtD
Ixabepilone—TUBB4B—Metabolism of proteins—EEF2—kidney cancer	2.8e-05	0.00201	CbGpPWpGaD
Ixabepilone—Mental disorder—Capecitabine—kidney cancer	2.79e-05	0.000369	CcSEcCtD
Ixabepilone—Asthenia—Dactinomycin—kidney cancer	2.79e-05	0.000369	CcSEcCtD
Ixabepilone—Malnutrition—Capecitabine—kidney cancer	2.77e-05	0.000367	CcSEcCtD
Ixabepilone—Dehydration—Doxorubicin—kidney cancer	2.76e-05	0.000365	CcSEcCtD
Ixabepilone—TUBB3—Metabolism of proteins—MME—kidney cancer	2.76e-05	0.00198	CbGpPWpGaD
Ixabepilone—Oedema—Paclitaxel—kidney cancer	2.76e-05	0.000365	CcSEcCtD
Ixabepilone—Abdominal pain—Vincristine—kidney cancer	2.75e-05	0.000363	CcSEcCtD
Ixabepilone—Body temperature increased—Vincristine—kidney cancer	2.75e-05	0.000363	CcSEcCtD
Ixabepilone—Infection—Paclitaxel—kidney cancer	2.74e-05	0.000362	CcSEcCtD
Ixabepilone—Dizziness—Sunitinib—kidney cancer	2.72e-05	0.000359	CcSEcCtD
Ixabepilone—Shock—Paclitaxel—kidney cancer	2.72e-05	0.000359	CcSEcCtD
Ixabepilone—Vomiting—Sorafenib—kidney cancer	2.71e-05	0.000359	CcSEcCtD
Ixabepilone—Nervous system disorder—Paclitaxel—kidney cancer	2.71e-05	0.000358	CcSEcCtD
Ixabepilone—Hypokalaemia—Doxorubicin—kidney cancer	2.7e-05	0.000357	CcSEcCtD
Ixabepilone—Thrombocytopenia—Paclitaxel—kidney cancer	2.7e-05	0.000357	CcSEcCtD
Ixabepilone—Rash—Sorafenib—kidney cancer	2.69e-05	0.000356	CcSEcCtD
Ixabepilone—Dermatitis—Sorafenib—kidney cancer	2.69e-05	0.000356	CcSEcCtD
Ixabepilone—Skin disorder—Paclitaxel—kidney cancer	2.68e-05	0.000354	CcSEcCtD
Ixabepilone—TUBB—Cell Cycle, Mitotic—PSMD7—kidney cancer	2.68e-05	0.00192	CbGpPWpGaD
Ixabepilone—Headache—Sorafenib—kidney cancer	2.67e-05	0.000354	CcSEcCtD
Ixabepilone—TUBB2A—Metabolism of proteins—MME—kidney cancer	2.67e-05	0.00191	CbGpPWpGaD
Ixabepilone—Muscle spasms—Capecitabine—kidney cancer	2.67e-05	0.000353	CcSEcCtD
Ixabepilone—Diarrhoea—Dactinomycin—kidney cancer	2.66e-05	0.000352	CcSEcCtD
Ixabepilone—TUBB2B—Metabolism of proteins—RPL14—kidney cancer	2.66e-05	0.0019	CbGpPWpGaD
Ixabepilone—TUBB6—Metabolism of proteins—HSPD1—kidney cancer	2.66e-05	0.0019	CbGpPWpGaD
Ixabepilone—TUBB6—Metabolism of proteins—RPL14—kidney cancer	2.66e-05	0.0019	CbGpPWpGaD
Ixabepilone—TUBB2B—Metabolism of proteins—HSPD1—kidney cancer	2.66e-05	0.0019	CbGpPWpGaD
Ixabepilone—Anorexia—Paclitaxel—kidney cancer	2.63e-05	0.000348	CcSEcCtD
Ixabepilone—Gastritis—Doxorubicin—kidney cancer	2.63e-05	0.000348	CcSEcCtD
Ixabepilone—Muscular weakness—Doxorubicin—kidney cancer	2.62e-05	0.000346	CcSEcCtD
Ixabepilone—TUBB1—Metabolism of proteins—MME—kidney cancer	2.61e-05	0.00187	CbGpPWpGaD
Ixabepilone—Vomiting—Sunitinib—kidney cancer	2.61e-05	0.000345	CcSEcCtD
Ixabepilone—Body temperature increased—Gemcitabine—kidney cancer	2.61e-05	0.000345	CcSEcCtD
Ixabepilone—TUBB—Cell Cycle, Mitotic—AURKA—kidney cancer	2.61e-05	0.00187	CbGpPWpGaD
Ixabepilone—Rash—Sunitinib—kidney cancer	2.59e-05	0.000342	CcSEcCtD
Ixabepilone—Dermatitis—Sunitinib—kidney cancer	2.59e-05	0.000342	CcSEcCtD
Ixabepilone—Hypotension—Paclitaxel—kidney cancer	2.58e-05	0.000341	CcSEcCtD
Ixabepilone—Headache—Sunitinib—kidney cancer	2.57e-05	0.00034	CcSEcCtD
Ixabepilone—Dysphagia—Doxorubicin—kidney cancer	2.57e-05	0.000339	CcSEcCtD
Ixabepilone—TUBB3—Metabolism of proteins—RPL14—kidney cancer	2.57e-05	0.00184	CbGpPWpGaD
Ixabepilone—TUBB3—Metabolism of proteins—HSPD1—kidney cancer	2.57e-05	0.00184	CbGpPWpGaD
Ixabepilone—Anaemia—Capecitabine—kidney cancer	2.56e-05	0.000339	CcSEcCtD
Ixabepilone—Hypersensitivity—Vincristine—kidney cancer	2.56e-05	0.000338	CcSEcCtD
Ixabepilone—Nausea—Sorafenib—kidney cancer	2.54e-05	0.000335	CcSEcCtD
Ixabepilone—Musculoskeletal discomfort—Paclitaxel—kidney cancer	2.51e-05	0.000332	CcSEcCtD
Ixabepilone—Angina pectoris—Doxorubicin—kidney cancer	2.5e-05	0.000331	CcSEcCtD
Ixabepilone—Insomnia—Paclitaxel—kidney cancer	2.5e-05	0.00033	CcSEcCtD
Ixabepilone—Asthenia—Vincristine—kidney cancer	2.49e-05	0.00033	CcSEcCtD
Ixabepilone—Syncope—Capecitabine—kidney cancer	2.49e-05	0.000329	CcSEcCtD
Ixabepilone—TUBB2A—Metabolism of proteins—RPL14—kidney cancer	2.49e-05	0.00178	CbGpPWpGaD
Ixabepilone—TUBB2A—Metabolism of proteins—HSPD1—kidney cancer	2.49e-05	0.00178	CbGpPWpGaD
Ixabepilone—Leukopenia—Capecitabine—kidney cancer	2.48e-05	0.000328	CcSEcCtD
Ixabepilone—Paraesthesia—Paclitaxel—kidney cancer	2.48e-05	0.000328	CcSEcCtD
Ixabepilone—Vomiting—Dactinomycin—kidney cancer	2.47e-05	0.000327	CcSEcCtD
Ixabepilone—Dyspnoea—Paclitaxel—kidney cancer	2.46e-05	0.000325	CcSEcCtD
Ixabepilone—Rash—Dactinomycin—kidney cancer	2.45e-05	0.000324	CcSEcCtD
Ixabepilone—Nausea—Sunitinib—kidney cancer	2.44e-05	0.000323	CcSEcCtD
Ixabepilone—Loss of consciousness—Capecitabine—kidney cancer	2.44e-05	0.000322	CcSEcCtD
Ixabepilone—Pancytopenia—Doxorubicin—kidney cancer	2.44e-05	0.000322	CcSEcCtD
Ixabepilone—TUBB1—Metabolism of proteins—HSPD1—kidney cancer	2.43e-05	0.00174	CbGpPWpGaD
Ixabepilone—TUBB1—Metabolism of proteins—RPL14—kidney cancer	2.43e-05	0.00174	CbGpPWpGaD
Ixabepilone—Cough—Capecitabine—kidney cancer	2.42e-05	0.00032	CcSEcCtD
Ixabepilone—Neutropenia—Doxorubicin—kidney cancer	2.4e-05	0.000317	CcSEcCtD
Ixabepilone—Decreased appetite—Paclitaxel—kidney cancer	2.4e-05	0.000317	CcSEcCtD
Ixabepilone—TUBB—Cell Cycle—PSMD7—kidney cancer	2.39e-05	0.00171	CbGpPWpGaD
Ixabepilone—Upper respiratory tract infection—Doxorubicin—kidney cancer	2.39e-05	0.000315	CcSEcCtD
Ixabepilone—Gastrointestinal disorder—Paclitaxel—kidney cancer	2.38e-05	0.000315	CcSEcCtD
Ixabepilone—Fatigue—Paclitaxel—kidney cancer	2.38e-05	0.000315	CcSEcCtD
Ixabepilone—Diarrhoea—Vincristine—kidney cancer	2.38e-05	0.000314	CcSEcCtD
Ixabepilone—Asthenia—Gemcitabine—kidney cancer	2.36e-05	0.000313	CcSEcCtD
Ixabepilone—Chest pain—Capecitabine—kidney cancer	2.36e-05	0.000312	CcSEcCtD
Ixabepilone—Arthralgia—Capecitabine—kidney cancer	2.36e-05	0.000312	CcSEcCtD
Ixabepilone—Myalgia—Capecitabine—kidney cancer	2.36e-05	0.000312	CcSEcCtD
Ixabepilone—Constipation—Paclitaxel—kidney cancer	2.36e-05	0.000312	CcSEcCtD
Ixabepilone—Pain—Paclitaxel—kidney cancer	2.36e-05	0.000312	CcSEcCtD
Ixabepilone—TUBB4A—Metabolism of proteins—MME—kidney cancer	2.35e-05	0.00168	CbGpPWpGaD
Ixabepilone—Unspecified disorder of skin and subcutaneous tissue—Capecitabine—kidney cancer	2.35e-05	0.00031	CcSEcCtD
Ixabepilone—CYP3A4—Constitutive Androstane Receptor Pathway—ABCB1—kidney cancer	2.34e-05	0.00168	CbGpPWpGaD
Ixabepilone—Pruritus—Gemcitabine—kidney cancer	2.33e-05	0.000308	CcSEcCtD
Ixabepilone—TUBB—Cell Cycle—AURKA—kidney cancer	2.33e-05	0.00167	CbGpPWpGaD
Ixabepilone—Weight decreased—Doxorubicin—kidney cancer	2.32e-05	0.000307	CcSEcCtD
Ixabepilone—Nausea—Dactinomycin—kidney cancer	2.31e-05	0.000305	CcSEcCtD
Ixabepilone—Pneumonia—Doxorubicin—kidney cancer	2.3e-05	0.000304	CcSEcCtD
Ixabepilone—Dizziness—Vincristine—kidney cancer	2.3e-05	0.000304	CcSEcCtD
Ixabepilone—Infestation—Doxorubicin—kidney cancer	2.29e-05	0.000303	CcSEcCtD
Ixabepilone—Infestation NOS—Doxorubicin—kidney cancer	2.29e-05	0.000303	CcSEcCtD
Ixabepilone—Oedema—Capecitabine—kidney cancer	2.26e-05	0.000299	CcSEcCtD
Ixabepilone—Gastrointestinal pain—Paclitaxel—kidney cancer	2.26e-05	0.000298	CcSEcCtD
Ixabepilone—Diarrhoea—Gemcitabine—kidney cancer	2.26e-05	0.000298	CcSEcCtD
Ixabepilone—Renal failure—Doxorubicin—kidney cancer	2.25e-05	0.000297	CcSEcCtD
Ixabepilone—Infection—Capecitabine—kidney cancer	2.25e-05	0.000297	CcSEcCtD
Ixabepilone—Neuropathy peripheral—Doxorubicin—kidney cancer	2.24e-05	0.000297	CcSEcCtD
Ixabepilone—Stomatitis—Doxorubicin—kidney cancer	2.23e-05	0.000295	CcSEcCtD
Ixabepilone—Jaundice—Doxorubicin—kidney cancer	2.23e-05	0.000295	CcSEcCtD
Ixabepilone—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB1—kidney cancer	2.23e-05	0.0016	CbGpPWpGaD
Ixabepilone—Shock—Capecitabine—kidney cancer	2.23e-05	0.000295	CcSEcCtD
Ixabepilone—Urinary tract infection—Doxorubicin—kidney cancer	2.22e-05	0.000294	CcSEcCtD
Ixabepilone—Nervous system disorder—Capecitabine—kidney cancer	2.22e-05	0.000294	CcSEcCtD
Ixabepilone—TUBB4A—Cell Cycle, Mitotic—PSMD7—kidney cancer	2.22e-05	0.00159	CbGpPWpGaD
Ixabepilone—Thrombocytopenia—Capecitabine—kidney cancer	2.22e-05	0.000293	CcSEcCtD
Ixabepilone—Vomiting—Vincristine—kidney cancer	2.21e-05	0.000292	CcSEcCtD
Ixabepilone—Skin disorder—Capecitabine—kidney cancer	2.2e-05	0.000291	CcSEcCtD
Ixabepilone—TUBB6—Metabolism of proteins—ACHE—kidney cancer	2.19e-05	0.00157	CbGpPWpGaD
Ixabepilone—TUBB2B—Metabolism of proteins—ACHE—kidney cancer	2.19e-05	0.00157	CbGpPWpGaD
Ixabepilone—Rash—Vincristine—kidney cancer	2.19e-05	0.00029	CcSEcCtD
Ixabepilone—Dermatitis—Vincristine—kidney cancer	2.19e-05	0.000289	CcSEcCtD
Ixabepilone—TUBB4A—Metabolism of proteins—HSPD1—kidney cancer	2.18e-05	0.00156	CbGpPWpGaD
Ixabepilone—TUBB4A—Metabolism of proteins—RPL14—kidney cancer	2.18e-05	0.00156	CbGpPWpGaD
Ixabepilone—Body temperature increased—Paclitaxel—kidney cancer	2.18e-05	0.000288	CcSEcCtD
Ixabepilone—Abdominal pain—Paclitaxel—kidney cancer	2.18e-05	0.000288	CcSEcCtD
Ixabepilone—Headache—Vincristine—kidney cancer	2.18e-05	0.000288	CcSEcCtD
Ixabepilone—TUBB6—Metabolism of proteins—EIF4EBP1—kidney cancer	2.17e-05	0.00155	CbGpPWpGaD
Ixabepilone—TUBB2B—Metabolism of proteins—EIF4EBP1—kidney cancer	2.17e-05	0.00155	CbGpPWpGaD
Ixabepilone—Hepatobiliary disease—Doxorubicin—kidney cancer	2.16e-05	0.000286	CcSEcCtD
Ixabepilone—Anorexia—Capecitabine—kidney cancer	2.16e-05	0.000285	CcSEcCtD
Ixabepilone—TUBB4A—Cell Cycle, Mitotic—AURKA—kidney cancer	2.16e-05	0.00155	CbGpPWpGaD
Ixabepilone—TUBB4B—Metabolism of proteins—MME—kidney cancer	2.15e-05	0.00154	CbGpPWpGaD
Ixabepilone—TUBB3—Metabolism of proteins—ACHE—kidney cancer	2.12e-05	0.00152	CbGpPWpGaD
Ixabepilone—Hypotension—Capecitabine—kidney cancer	2.12e-05	0.00028	CcSEcCtD
Ixabepilone—Vomiting—Gemcitabine—kidney cancer	2.1e-05	0.000277	CcSEcCtD
Ixabepilone—TUBB3—Metabolism of proteins—EIF4EBP1—kidney cancer	2.09e-05	0.0015	CbGpPWpGaD
Ixabepilone—TUBB2B—Metabolism of proteins—PAX6—kidney cancer	2.09e-05	0.00149	CbGpPWpGaD
Ixabepilone—TUBB6—Metabolism of proteins—PAX6—kidney cancer	2.09e-05	0.00149	CbGpPWpGaD
Ixabepilone—Rash—Gemcitabine—kidney cancer	2.08e-05	0.000275	CcSEcCtD
Ixabepilone—Dermatitis—Gemcitabine—kidney cancer	2.08e-05	0.000275	CcSEcCtD
Ixabepilone—TUBB6—Transmembrane transport of small molecules—SLC5A5—kidney cancer	2.08e-05	0.00149	CbGpPWpGaD
Ixabepilone—TUBB2B—Transmembrane transport of small molecules—SLC5A5—kidney cancer	2.08e-05	0.00149	CbGpPWpGaD
Ixabepilone—TUBB6—Metabolism of proteins—CTSD—kidney cancer	2.07e-05	0.00149	CbGpPWpGaD
Ixabepilone—TUBB2B—Metabolism of proteins—CTSD—kidney cancer	2.07e-05	0.00149	CbGpPWpGaD
Ixabepilone—Haemoglobin—Doxorubicin—kidney cancer	2.07e-05	0.000273	CcSEcCtD
Ixabepilone—Headache—Gemcitabine—kidney cancer	2.06e-05	0.000273	CcSEcCtD
Ixabepilone—Nausea—Vincristine—kidney cancer	2.06e-05	0.000273	CcSEcCtD
Ixabepilone—Musculoskeletal discomfort—Capecitabine—kidney cancer	2.06e-05	0.000273	CcSEcCtD
Ixabepilone—Haemorrhage—Doxorubicin—kidney cancer	2.05e-05	0.000272	CcSEcCtD
Ixabepilone—TUBB2A—Metabolism of proteins—ACHE—kidney cancer	2.05e-05	0.00147	CbGpPWpGaD
Ixabepilone—Insomnia—Capecitabine—kidney cancer	2.05e-05	0.000271	CcSEcCtD
Ixabepilone—Hypoaesthesia—Doxorubicin—kidney cancer	2.04e-05	0.00027	CcSEcCtD
Ixabepilone—Paraesthesia—Capecitabine—kidney cancer	2.03e-05	0.000269	CcSEcCtD
Ixabepilone—Hypersensitivity—Paclitaxel—kidney cancer	2.03e-05	0.000269	CcSEcCtD
Ixabepilone—TUBB4B—Cell Cycle, Mitotic—PSMD7—kidney cancer	2.03e-05	0.00145	CbGpPWpGaD
Ixabepilone—Urinary tract disorder—Doxorubicin—kidney cancer	2.03e-05	0.000268	CcSEcCtD
Ixabepilone—TUBB2A—Metabolism of proteins—EIF4EBP1—kidney cancer	2.03e-05	0.00145	CbGpPWpGaD
Ixabepilone—Connective tissue disorder—Doxorubicin—kidney cancer	2.02e-05	0.000267	CcSEcCtD
Ixabepilone—Dyspnoea—Capecitabine—kidney cancer	2.02e-05	0.000267	CcSEcCtD
Ixabepilone—Urethral disorder—Doxorubicin—kidney cancer	2.01e-05	0.000266	CcSEcCtD
Ixabepilone—TUBB3—Metabolism of proteins—PAX6—kidney cancer	2.01e-05	0.00144	CbGpPWpGaD
Ixabepilone—TUBB1—Metabolism of proteins—ACHE—kidney cancer	2e-05	0.00144	CbGpPWpGaD
Ixabepilone—TUBB3—Transmembrane transport of small molecules—SLC5A5—kidney cancer	2e-05	0.00144	CbGpPWpGaD
Ixabepilone—TUBB6—Transmembrane transport of small molecules—SLC2A1—kidney cancer	2e-05	0.00144	CbGpPWpGaD
Ixabepilone—TUBB2B—Transmembrane transport of small molecules—SLC2A1—kidney cancer	2e-05	0.00144	CbGpPWpGaD
Ixabepilone—TUBB3—Metabolism of proteins—CTSD—kidney cancer	2e-05	0.00143	CbGpPWpGaD
Ixabepilone—TUBB4B—Metabolism of proteins—HSPD1—kidney cancer	2e-05	0.00143	CbGpPWpGaD
Ixabepilone—TUBB4B—Metabolism of proteins—RPL14—kidney cancer	2e-05	0.00143	CbGpPWpGaD
Ixabepilone—TUBB4A—Cell Cycle—PSMD7—kidney cancer	1.98e-05	0.00142	CbGpPWpGaD
Ixabepilone—TUBB1—Metabolism of proteins—EIF4EBP1—kidney cancer	1.98e-05	0.00142	CbGpPWpGaD
Ixabepilone—Asthenia—Paclitaxel—kidney cancer	1.98e-05	0.000262	CcSEcCtD
Ixabepilone—TUBB4B—Cell Cycle, Mitotic—AURKA—kidney cancer	1.97e-05	0.00141	CbGpPWpGaD
Ixabepilone—Decreased appetite—Capecitabine—kidney cancer	1.97e-05	0.00026	CcSEcCtD
Ixabepilone—Nausea—Gemcitabine—kidney cancer	1.96e-05	0.000259	CcSEcCtD
Ixabepilone—TUBB—Cell Cycle, Mitotic—CDKN2B—kidney cancer	1.96e-05	0.0014	CbGpPWpGaD
Ixabepilone—Gastrointestinal disorder—Capecitabine—kidney cancer	1.96e-05	0.000259	CcSEcCtD
Ixabepilone—Fatigue—Capecitabine—kidney cancer	1.95e-05	0.000258	CcSEcCtD
Ixabepilone—Pruritus—Paclitaxel—kidney cancer	1.95e-05	0.000258	CcSEcCtD
Ixabepilone—TUBB2A—Metabolism of proteins—PAX6—kidney cancer	1.95e-05	0.0014	CbGpPWpGaD
Ixabepilone—Erythema multiforme—Doxorubicin—kidney cancer	1.94e-05	0.000257	CcSEcCtD
Ixabepilone—TUBB2A—Transmembrane transport of small molecules—SLC5A5—kidney cancer	1.94e-05	0.00139	CbGpPWpGaD
Ixabepilone—TUBB2A—Metabolism of proteins—CTSD—kidney cancer	1.94e-05	0.00139	CbGpPWpGaD
Ixabepilone—Pain—Capecitabine—kidney cancer	1.94e-05	0.000256	CcSEcCtD
Ixabepilone—Constipation—Capecitabine—kidney cancer	1.94e-05	0.000256	CcSEcCtD
Ixabepilone—TUBB3—Transmembrane transport of small molecules—SLC2A1—kidney cancer	1.94e-05	0.00139	CbGpPWpGaD
Ixabepilone—TUBB4A—Cell Cycle—AURKA—kidney cancer	1.93e-05	0.00138	CbGpPWpGaD
Ixabepilone—Eye disorder—Doxorubicin—kidney cancer	1.92e-05	0.000254	CcSEcCtD
Ixabepilone—TUBB2B—Metabolism of proteins—BCHE—kidney cancer	1.91e-05	0.00137	CbGpPWpGaD
Ixabepilone—TUBB6—Metabolism of proteins—BCHE—kidney cancer	1.91e-05	0.00137	CbGpPWpGaD
Ixabepilone—TUBB1—Metabolism of proteins—PAX6—kidney cancer	1.91e-05	0.00137	CbGpPWpGaD
Ixabepilone—Cardiac disorder—Doxorubicin—kidney cancer	1.91e-05	0.000252	CcSEcCtD
Ixabepilone—TUBB1—Transmembrane transport of small molecules—SLC5A5—kidney cancer	1.9e-05	0.00136	CbGpPWpGaD
Ixabepilone—TUBB1—Metabolism of proteins—CTSD—kidney cancer	1.9e-05	0.00136	CbGpPWpGaD
Ixabepilone—Diarrhoea—Paclitaxel—kidney cancer	1.89e-05	0.00025	CcSEcCtD
Ixabepilone—TUBB2A—Transmembrane transport of small molecules—SLC2A1—kidney cancer	1.87e-05	0.00134	CbGpPWpGaD
Ixabepilone—Angiopathy—Doxorubicin—kidney cancer	1.86e-05	0.000246	CcSEcCtD
Ixabepilone—Immune system disorder—Doxorubicin—kidney cancer	1.86e-05	0.000245	CcSEcCtD
Ixabepilone—Gastrointestinal pain—Capecitabine—kidney cancer	1.85e-05	0.000245	CcSEcCtD
Ixabepilone—Mediastinal disorder—Doxorubicin—kidney cancer	1.85e-05	0.000245	CcSEcCtD
Ixabepilone—TUBB3—Metabolism of proteins—BCHE—kidney cancer	1.84e-05	0.00132	CbGpPWpGaD
Ixabepilone—Chills—Doxorubicin—kidney cancer	1.84e-05	0.000244	CcSEcCtD
Ixabepilone—TUBB1—Transmembrane transport of small molecules—SLC2A1—kidney cancer	1.83e-05	0.00131	CbGpPWpGaD
Ixabepilone—Dizziness—Paclitaxel—kidney cancer	1.82e-05	0.000241	CcSEcCtD
Ixabepilone—Alopecia—Doxorubicin—kidney cancer	1.82e-05	0.00024	CcSEcCtD
Ixabepilone—TUBB4B—Cell Cycle—PSMD7—kidney cancer	1.81e-05	0.0013	CbGpPWpGaD
Ixabepilone—Mental disorder—Doxorubicin—kidney cancer	1.8e-05	0.000238	CcSEcCtD
Ixabepilone—TUBB4A—Metabolism of proteins—ACHE—kidney cancer	1.8e-05	0.00129	CbGpPWpGaD
Ixabepilone—Body temperature increased—Capecitabine—kidney cancer	1.79e-05	0.000237	CcSEcCtD
Ixabepilone—Abdominal pain—Capecitabine—kidney cancer	1.79e-05	0.000237	CcSEcCtD
Ixabepilone—Malnutrition—Doxorubicin—kidney cancer	1.79e-05	0.000236	CcSEcCtD
Ixabepilone—TUBB2A—Metabolism of proteins—BCHE—kidney cancer	1.79e-05	0.00128	CbGpPWpGaD
Ixabepilone—TUBB4A—Metabolism of proteins—EIF4EBP1—kidney cancer	1.78e-05	0.00127	CbGpPWpGaD
Ixabepilone—TUBB4B—Cell Cycle—AURKA—kidney cancer	1.77e-05	0.00126	CbGpPWpGaD
Ixabepilone—TUBB—Cell Cycle—BRCA2—kidney cancer	1.77e-05	0.00126	CbGpPWpGaD
Ixabepilone—Vomiting—Paclitaxel—kidney cancer	1.75e-05	0.000232	CcSEcCtD
Ixabepilone—TUBB—Cell Cycle—CDKN2B—kidney cancer	1.75e-05	0.00125	CbGpPWpGaD
Ixabepilone—TUBB1—Metabolism of proteins—BCHE—kidney cancer	1.75e-05	0.00125	CbGpPWpGaD
Ixabepilone—Rash—Paclitaxel—kidney cancer	1.74e-05	0.00023	CcSEcCtD
Ixabepilone—Dermatitis—Paclitaxel—kidney cancer	1.74e-05	0.00023	CcSEcCtD
Ixabepilone—Headache—Paclitaxel—kidney cancer	1.73e-05	0.000229	CcSEcCtD
Ixabepilone—Muscle spasms—Doxorubicin—kidney cancer	1.72e-05	0.000227	CcSEcCtD
Ixabepilone—TUBB4A—Metabolism of proteins—PAX6—kidney cancer	1.71e-05	0.00123	CbGpPWpGaD
Ixabepilone—TUBB4A—Transmembrane transport of small molecules—SLC5A5—kidney cancer	1.7e-05	0.00122	CbGpPWpGaD
Ixabepilone—TUBB4A—Metabolism of proteins—CTSD—kidney cancer	1.7e-05	0.00122	CbGpPWpGaD
Ixabepilone—TUBB—Cell Cycle, Mitotic—BIRC5—kidney cancer	1.69e-05	0.00121	CbGpPWpGaD
Ixabepilone—Hypersensitivity—Capecitabine—kidney cancer	1.67e-05	0.000221	CcSEcCtD
Ixabepilone—Anaemia—Doxorubicin—kidney cancer	1.65e-05	0.000219	CcSEcCtD
Ixabepilone—TUBB4B—Metabolism of proteins—ACHE—kidney cancer	1.65e-05	0.00118	CbGpPWpGaD
Ixabepilone—TUBB4A—Transmembrane transport of small molecules—SLC2A1—kidney cancer	1.65e-05	0.00118	CbGpPWpGaD
Ixabepilone—Nausea—Paclitaxel—kidney cancer	1.64e-05	0.000217	CcSEcCtD
Ixabepilone—CYP3A4—Phase 1 - Functionalization of compounds—PTGS1—kidney cancer	1.64e-05	0.00117	CbGpPWpGaD
Ixabepilone—TUBB4B—Metabolism of proteins—EIF4EBP1—kidney cancer	1.63e-05	0.00117	CbGpPWpGaD
Ixabepilone—Asthenia—Capecitabine—kidney cancer	1.62e-05	0.000215	CcSEcCtD
Ixabepilone—TUBB4A—Cell Cycle, Mitotic—CDKN2B—kidney cancer	1.62e-05	0.00116	CbGpPWpGaD
Ixabepilone—CYP3A4—Tryptophan metabolism—CYP1A1—kidney cancer	1.61e-05	0.00115	CbGpPWpGaD
Ixabepilone—Syncope—Doxorubicin—kidney cancer	1.6e-05	0.000212	CcSEcCtD
Ixabepilone—Pruritus—Capecitabine—kidney cancer	1.6e-05	0.000212	CcSEcCtD
Ixabepilone—Leukopenia—Doxorubicin—kidney cancer	1.6e-05	0.000212	CcSEcCtD
Ixabepilone—TUBB2B—Transmembrane transport of small molecules—ABCB1—kidney cancer	1.58e-05	0.00113	CbGpPWpGaD
Ixabepilone—TUBB6—Transmembrane transport of small molecules—ABCB1—kidney cancer	1.58e-05	0.00113	CbGpPWpGaD
Ixabepilone—CYP3A4—Biological oxidations—ALDH1A1—kidney cancer	1.58e-05	0.00113	CbGpPWpGaD
Ixabepilone—Loss of consciousness—Doxorubicin—kidney cancer	1.57e-05	0.000208	CcSEcCtD
Ixabepilone—TUBB4A—Metabolism of proteins—BCHE—kidney cancer	1.57e-05	0.00112	CbGpPWpGaD
Ixabepilone—TUBB4B—Metabolism of proteins—PAX6—kidney cancer	1.57e-05	0.00112	CbGpPWpGaD
Ixabepilone—Cough—Doxorubicin—kidney cancer	1.56e-05	0.000206	CcSEcCtD
Ixabepilone—TUBB4B—Transmembrane transport of small molecules—SLC5A5—kidney cancer	1.56e-05	0.00112	CbGpPWpGaD
Ixabepilone—TUBB4B—Metabolism of proteins—CTSD—kidney cancer	1.56e-05	0.00112	CbGpPWpGaD
Ixabepilone—Diarrhoea—Capecitabine—kidney cancer	1.55e-05	0.000205	CcSEcCtD
Ixabepilone—TUBB3—Transmembrane transport of small molecules—ABCB1—kidney cancer	1.53e-05	0.00109	CbGpPWpGaD
Ixabepilone—Myalgia—Doxorubicin—kidney cancer	1.52e-05	0.000201	CcSEcCtD
Ixabepilone—Chest pain—Doxorubicin—kidney cancer	1.52e-05	0.000201	CcSEcCtD
Ixabepilone—Arthralgia—Doxorubicin—kidney cancer	1.52e-05	0.000201	CcSEcCtD
Ixabepilone—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—kidney cancer	1.51e-05	0.0002	CcSEcCtD
Ixabepilone—TUBB—Cell Cycle—BIRC5—kidney cancer	1.51e-05	0.00108	CbGpPWpGaD
Ixabepilone—TUBB4B—Transmembrane transport of small molecules—SLC2A1—kidney cancer	1.51e-05	0.00108	CbGpPWpGaD
Ixabepilone—Dizziness—Capecitabine—kidney cancer	1.5e-05	0.000198	CcSEcCtD
Ixabepilone—TUBB4B—Cell Cycle, Mitotic—CDKN2B—kidney cancer	1.48e-05	0.00106	CbGpPWpGaD
Ixabepilone—TUBB2A—Transmembrane transport of small molecules—ABCB1—kidney cancer	1.48e-05	0.00106	CbGpPWpGaD
Ixabepilone—TUBB2B—Metabolism of proteins—IGF2—kidney cancer	1.48e-05	0.00106	CbGpPWpGaD
Ixabepilone—TUBB6—Metabolism of proteins—IGF2—kidney cancer	1.48e-05	0.00106	CbGpPWpGaD
Ixabepilone—TUBB4A—Cell Cycle—BRCA2—kidney cancer	1.46e-05	0.00105	CbGpPWpGaD
Ixabepilone—Oedema—Doxorubicin—kidney cancer	1.46e-05	0.000193	CcSEcCtD
Ixabepilone—Infection—Doxorubicin—kidney cancer	1.45e-05	0.000192	CcSEcCtD
Ixabepilone—TUBB4A—Cell Cycle—CDKN2B—kidney cancer	1.45e-05	0.00104	CbGpPWpGaD
Ixabepilone—TUBB1—Transmembrane transport of small molecules—ABCB1—kidney cancer	1.45e-05	0.00104	CbGpPWpGaD
Ixabepilone—Vomiting—Capecitabine—kidney cancer	1.44e-05	0.00019	CcSEcCtD
Ixabepilone—Shock—Doxorubicin—kidney cancer	1.44e-05	0.00019	CcSEcCtD
Ixabepilone—TUBB4B—Metabolism of proteins—BCHE—kidney cancer	1.43e-05	0.00103	CbGpPWpGaD
Ixabepilone—Nervous system disorder—Doxorubicin—kidney cancer	1.43e-05	0.000189	CcSEcCtD
Ixabepilone—Thrombocytopenia—Doxorubicin—kidney cancer	1.43e-05	0.000189	CcSEcCtD
Ixabepilone—Rash—Capecitabine—kidney cancer	1.43e-05	0.000189	CcSEcCtD
Ixabepilone—TUBB3—Metabolism of proteins—IGF2—kidney cancer	1.43e-05	0.00102	CbGpPWpGaD
Ixabepilone—Dermatitis—Capecitabine—kidney cancer	1.43e-05	0.000189	CcSEcCtD
Ixabepilone—Headache—Capecitabine—kidney cancer	1.42e-05	0.000188	CcSEcCtD
Ixabepilone—Skin disorder—Doxorubicin—kidney cancer	1.42e-05	0.000187	CcSEcCtD
Ixabepilone—TUBB4A—Cell Cycle, Mitotic—BIRC5—kidney cancer	1.4e-05	0.001	CbGpPWpGaD
Ixabepilone—Anorexia—Doxorubicin—kidney cancer	1.39e-05	0.000184	CcSEcCtD
Ixabepilone—TUBB2A—Metabolism of proteins—IGF2—kidney cancer	1.38e-05	0.00099	CbGpPWpGaD
Ixabepilone—Hypotension—Doxorubicin—kidney cancer	1.36e-05	0.00018	CcSEcCtD
Ixabepilone—TUBB1—Metabolism of proteins—IGF2—kidney cancer	1.35e-05	0.000968	CbGpPWpGaD
Ixabepilone—Nausea—Capecitabine—kidney cancer	1.35e-05	0.000178	CcSEcCtD
Ixabepilone—TUBB4B—Cell Cycle—BRCA2—kidney cancer	1.34e-05	0.000958	CbGpPWpGaD
Ixabepilone—Musculoskeletal discomfort—Doxorubicin—kidney cancer	1.33e-05	0.000176	CcSEcCtD
Ixabepilone—TUBB4B—Cell Cycle—CDKN2B—kidney cancer	1.33e-05	0.00095	CbGpPWpGaD
Ixabepilone—Insomnia—Doxorubicin—kidney cancer	1.32e-05	0.000175	CcSEcCtD
Ixabepilone—Paraesthesia—Doxorubicin—kidney cancer	1.31e-05	0.000173	CcSEcCtD
Ixabepilone—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP1A1—kidney cancer	1.3e-05	0.000933	CbGpPWpGaD
Ixabepilone—Dyspnoea—Doxorubicin—kidney cancer	1.3e-05	0.000172	CcSEcCtD
Ixabepilone—TUBB4A—Transmembrane transport of small molecules—ABCB1—kidney cancer	1.3e-05	0.000931	CbGpPWpGaD
Ixabepilone—CYP3A4—Oxidation by Cytochrome P450—CYP1A1—kidney cancer	1.29e-05	0.000921	CbGpPWpGaD
Ixabepilone—TUBB4B—Cell Cycle, Mitotic—BIRC5—kidney cancer	1.28e-05	0.000917	CbGpPWpGaD
Ixabepilone—Decreased appetite—Doxorubicin—kidney cancer	1.27e-05	0.000168	CcSEcCtD
Ixabepilone—Gastrointestinal disorder—Doxorubicin—kidney cancer	1.26e-05	0.000167	CcSEcCtD
Ixabepilone—Fatigue—Doxorubicin—kidney cancer	1.26e-05	0.000166	CcSEcCtD
Ixabepilone—TUBB4A—Cell Cycle—BIRC5—kidney cancer	1.25e-05	0.000896	CbGpPWpGaD
Ixabepilone—Pain—Doxorubicin—kidney cancer	1.25e-05	0.000165	CcSEcCtD
Ixabepilone—Constipation—Doxorubicin—kidney cancer	1.25e-05	0.000165	CcSEcCtD
Ixabepilone—TUBB4A—Metabolism of proteins—IGF2—kidney cancer	1.21e-05	0.000869	CbGpPWpGaD
Ixabepilone—Gastrointestinal pain—Doxorubicin—kidney cancer	1.19e-05	0.000158	CcSEcCtD
Ixabepilone—TUBB4B—Transmembrane transport of small molecules—ABCB1—kidney cancer	1.19e-05	0.000851	CbGpPWpGaD
Ixabepilone—Abdominal pain—Doxorubicin—kidney cancer	1.15e-05	0.000153	CcSEcCtD
Ixabepilone—Body temperature increased—Doxorubicin—kidney cancer	1.15e-05	0.000153	CcSEcCtD
Ixabepilone—TUBB4B—Cell Cycle—BIRC5—kidney cancer	1.14e-05	0.00082	CbGpPWpGaD
Ixabepilone—TUBB—Cell Cycle, Mitotic—CDKN2A—kidney cancer	1.12e-05	0.000802	CbGpPWpGaD
Ixabepilone—TUBB4B—Metabolism of proteins—IGF2—kidney cancer	1.11e-05	0.000795	CbGpPWpGaD
Ixabepilone—Hypersensitivity—Doxorubicin—kidney cancer	1.08e-05	0.000142	CcSEcCtD
Ixabepilone—CYP3A4—Phase 1 - Functionalization of compounds—CYP1A1—kidney cancer	1.06e-05	0.000756	CbGpPWpGaD
Ixabepilone—Asthenia—Doxorubicin—kidney cancer	1.05e-05	0.000138	CcSEcCtD
Ixabepilone—Pruritus—Doxorubicin—kidney cancer	1.03e-05	0.000137	CcSEcCtD
Ixabepilone—TUBB—Cell Cycle—CDKN2A—kidney cancer	1e-05	0.000717	CbGpPWpGaD
Ixabepilone—Diarrhoea—Doxorubicin—kidney cancer	9.99e-06	0.000132	CcSEcCtD
Ixabepilone—TUBB—Cell Cycle, Mitotic—CDKN1B—kidney cancer	9.91e-06	0.00071	CbGpPWpGaD
Ixabepilone—TUBB6—Metabolism of proteins—POMC—kidney cancer	9.87e-06	0.000707	CbGpPWpGaD
Ixabepilone—TUBB2B—Metabolism of proteins—POMC—kidney cancer	9.87e-06	0.000707	CbGpPWpGaD
Ixabepilone—CYP3A4—Cytochrome P450 - arranged by substrate type—POMC—kidney cancer	9.71e-06	0.000695	CbGpPWpGaD
Ixabepilone—Dizziness—Doxorubicin—kidney cancer	9.65e-06	0.000128	CcSEcCtD
Ixabepilone—TUBB3—Metabolism of proteins—POMC—kidney cancer	9.53e-06	0.000682	CbGpPWpGaD
Ixabepilone—TUBB—Cell Cycle, Mitotic—CCND1—kidney cancer	9.46e-06	0.000677	CbGpPWpGaD
Ixabepilone—CYP3A4—Biological oxidations—GSTT1—kidney cancer	9.29e-06	0.000665	CbGpPWpGaD
Ixabepilone—Vomiting—Doxorubicin—kidney cancer	9.28e-06	0.000123	CcSEcCtD
Ixabepilone—TUBB4A—Cell Cycle, Mitotic—CDKN2A—kidney cancer	9.27e-06	0.000664	CbGpPWpGaD
Ixabepilone—TUBB2A—Metabolism of proteins—POMC—kidney cancer	9.23e-06	0.000661	CbGpPWpGaD
Ixabepilone—Rash—Doxorubicin—kidney cancer	9.2e-06	0.000122	CcSEcCtD
Ixabepilone—Dermatitis—Doxorubicin—kidney cancer	9.2e-06	0.000122	CcSEcCtD
Ixabepilone—Headache—Doxorubicin—kidney cancer	9.15e-06	0.000121	CcSEcCtD
Ixabepilone—TUBB1—Metabolism of proteins—POMC—kidney cancer	9.02e-06	0.000646	CbGpPWpGaD
Ixabepilone—TUBB2B—Transmembrane transport of small molecules—RAF1—kidney cancer	8.95e-06	0.000641	CbGpPWpGaD
Ixabepilone—TUBB6—Transmembrane transport of small molecules—RAF1—kidney cancer	8.95e-06	0.000641	CbGpPWpGaD
Ixabepilone—TUBB—Cell Cycle—CDKN1B—kidney cancer	8.86e-06	0.000635	CbGpPWpGaD
Ixabepilone—CYP3A4—Biological oxidations—PTGS1—kidney cancer	8.7e-06	0.000623	CbGpPWpGaD
Ixabepilone—Nausea—Doxorubicin—kidney cancer	8.67e-06	0.000115	CcSEcCtD
Ixabepilone—TUBB3—Transmembrane transport of small molecules—RAF1—kidney cancer	8.65e-06	0.000619	CbGpPWpGaD
Ixabepilone—TUBB4B—Cell Cycle, Mitotic—CDKN2A—kidney cancer	8.48e-06	0.000607	CbGpPWpGaD
Ixabepilone—TUBB—Cell Cycle—CCND1—kidney cancer	8.45e-06	0.000605	CbGpPWpGaD
Ixabepilone—TUBB2A—Transmembrane transport of small molecules—RAF1—kidney cancer	8.37e-06	0.0006	CbGpPWpGaD
Ixabepilone—TUBB4A—Cell Cycle—CDKN2A—kidney cancer	8.29e-06	0.000594	CbGpPWpGaD
Ixabepilone—TUBB4A—Cell Cycle, Mitotic—CDKN1B—kidney cancer	8.21e-06	0.000588	CbGpPWpGaD
Ixabepilone—TUBB1—Transmembrane transport of small molecules—RAF1—kidney cancer	8.19e-06	0.000586	CbGpPWpGaD
Ixabepilone—TUBB4A—Metabolism of proteins—POMC—kidney cancer	8.1e-06	0.00058	CbGpPWpGaD
Ixabepilone—CYP3A4—Phase 1 - Functionalization of compounds—POMC—kidney cancer	7.87e-06	0.000564	CbGpPWpGaD
Ixabepilone—TUBB4A—Cell Cycle, Mitotic—CCND1—kidney cancer	7.84e-06	0.000561	CbGpPWpGaD
Ixabepilone—TUBB—Cell Cycle, Mitotic—MAPK3—kidney cancer	7.8e-06	0.000558	CbGpPWpGaD
Ixabepilone—TUBB—Cell Cycle, Mitotic—MYC—kidney cancer	7.58e-06	0.000543	CbGpPWpGaD
Ixabepilone—TUBB4B—Cell Cycle—CDKN2A—kidney cancer	7.58e-06	0.000543	CbGpPWpGaD
Ixabepilone—TUBB4B—Cell Cycle, Mitotic—CDKN1B—kidney cancer	7.51e-06	0.000538	CbGpPWpGaD
Ixabepilone—TUBB—Cell Cycle, Mitotic—MAPK1—kidney cancer	7.42e-06	0.000531	CbGpPWpGaD
Ixabepilone—TUBB4B—Metabolism of proteins—POMC—kidney cancer	7.41e-06	0.000531	CbGpPWpGaD
Ixabepilone—TUBB4A—Transmembrane transport of small molecules—RAF1—kidney cancer	7.35e-06	0.000527	CbGpPWpGaD
Ixabepilone—TUBB4A—Cell Cycle—CDKN1B—kidney cancer	7.34e-06	0.000526	CbGpPWpGaD
Ixabepilone—TUBB4B—Cell Cycle, Mitotic—CCND1—kidney cancer	7.17e-06	0.000513	CbGpPWpGaD
Ixabepilone—TUBB2B—Metabolism of proteins—CTNNB1—kidney cancer	7.04e-06	0.000504	CbGpPWpGaD
Ixabepilone—TUBB6—Metabolism of proteins—CTNNB1—kidney cancer	7.04e-06	0.000504	CbGpPWpGaD
Ixabepilone—TUBB4A—Cell Cycle—CCND1—kidney cancer	7.01e-06	0.000502	CbGpPWpGaD
Ixabepilone—TUBB—Cell Cycle—MAPK3—kidney cancer	6.97e-06	0.000499	CbGpPWpGaD
Ixabepilone—TUBB3—Metabolism of proteins—CTNNB1—kidney cancer	6.8e-06	0.000487	CbGpPWpGaD
Ixabepilone—TUBB—Cell Cycle—MYC—kidney cancer	6.78e-06	0.000486	CbGpPWpGaD
Ixabepilone—TUBB4B—Transmembrane transport of small molecules—RAF1—kidney cancer	6.72e-06	0.000482	CbGpPWpGaD
Ixabepilone—TUBB4B—Cell Cycle—CDKN1B—kidney cancer	6.72e-06	0.000481	CbGpPWpGaD
Ixabepilone—TUBB—Cell Cycle—MAPK1—kidney cancer	6.63e-06	0.000475	CbGpPWpGaD
Ixabepilone—TUBB2A—Metabolism of proteins—CTNNB1—kidney cancer	6.59e-06	0.000472	CbGpPWpGaD
Ixabepilone—TUBB4A—Cell Cycle, Mitotic—MAPK3—kidney cancer	6.46e-06	0.000463	CbGpPWpGaD
Ixabepilone—TUBB1—Metabolism of proteins—CTNNB1—kidney cancer	6.44e-06	0.000461	CbGpPWpGaD
Ixabepilone—CYP3A4—Biological oxidations—GSTP1—kidney cancer	6.44e-06	0.000461	CbGpPWpGaD
Ixabepilone—TUBB4B—Cell Cycle—CCND1—kidney cancer	6.41e-06	0.000459	CbGpPWpGaD
Ixabepilone—CYP3A4—Metapathway biotransformation—GSTP1—kidney cancer	6.35e-06	0.000455	CbGpPWpGaD
Ixabepilone—TUBB4A—Cell Cycle, Mitotic—MYC—kidney cancer	6.28e-06	0.00045	CbGpPWpGaD
Ixabepilone—TUBB4A—Cell Cycle, Mitotic—MAPK1—kidney cancer	6.15e-06	0.00044	CbGpPWpGaD
Ixabepilone—CYP3A4—Biological oxidations—GSTM1—kidney cancer	5.92e-06	0.000424	CbGpPWpGaD
Ixabepilone—TUBB4B—Cell Cycle, Mitotic—MAPK3—kidney cancer	5.91e-06	0.000423	CbGpPWpGaD
Ixabepilone—CYP3A4—Metapathway biotransformation—GSTM1—kidney cancer	5.84e-06	0.000418	CbGpPWpGaD
Ixabepilone—TUBB4A—Metabolism of proteins—CTNNB1—kidney cancer	5.78e-06	0.000414	CbGpPWpGaD
Ixabepilone—TUBB4A—Cell Cycle—MAPK3—kidney cancer	5.78e-06	0.000414	CbGpPWpGaD
Ixabepilone—TUBB4B—Cell Cycle, Mitotic—MYC—kidney cancer	5.75e-06	0.000412	CbGpPWpGaD
Ixabepilone—TUBB4B—Cell Cycle, Mitotic—MAPK1—kidney cancer	5.62e-06	0.000403	CbGpPWpGaD
Ixabepilone—TUBB4A—Cell Cycle—MYC—kidney cancer	5.62e-06	0.000402	CbGpPWpGaD
Ixabepilone—CYP3A4—Biological oxidations—CYP1A1—kidney cancer	5.61e-06	0.000402	CbGpPWpGaD
Ixabepilone—TUBB—Cell Cycle—TP53—kidney cancer	5.57e-06	0.000399	CbGpPWpGaD
Ixabepilone—CYP3A4—Metapathway biotransformation—CYP1A1—kidney cancer	5.53e-06	0.000396	CbGpPWpGaD
Ixabepilone—TUBB4A—Cell Cycle—MAPK1—kidney cancer	5.5e-06	0.000394	CbGpPWpGaD
Ixabepilone—TUBB4B—Metabolism of proteins—CTNNB1—kidney cancer	5.29e-06	0.000379	CbGpPWpGaD
Ixabepilone—TUBB4B—Cell Cycle—MAPK3—kidney cancer	5.28e-06	0.000378	CbGpPWpGaD
Ixabepilone—TUBB4B—Cell Cycle—MYC—kidney cancer	5.14e-06	0.000368	CbGpPWpGaD
Ixabepilone—TUBB4B—Cell Cycle—MAPK1—kidney cancer	5.03e-06	0.00036	CbGpPWpGaD
Ixabepilone—CYP3A4—Metabolism—ACY1—kidney cancer	4.93e-06	0.000353	CbGpPWpGaD
Ixabepilone—TUBB4A—Cell Cycle—TP53—kidney cancer	4.61e-06	0.00033	CbGpPWpGaD
Ixabepilone—TUBB4B—Cell Cycle—TP53—kidney cancer	4.22e-06	0.000302	CbGpPWpGaD
Ixabepilone—CYP3A4—Metabolism—PDHB—kidney cancer	4.19e-06	0.0003	CbGpPWpGaD
Ixabepilone—CYP3A4—Biological oxidations—POMC—kidney cancer	4.18e-06	0.000299	CbGpPWpGaD
Ixabepilone—CYP3A4—Metabolism—CCBL1—kidney cancer	3.94e-06	0.000282	CbGpPWpGaD
Ixabepilone—CYP3A4—Metabolism—GLIPR1—kidney cancer	3.42e-06	0.000245	CbGpPWpGaD
Ixabepilone—CYP3A4—Metabolism—PPAT—kidney cancer	3.42e-06	0.000245	CbGpPWpGaD
Ixabepilone—CYP3A4—Metabolism—FH—kidney cancer	3.18e-06	0.000228	CbGpPWpGaD
Ixabepilone—CYP3A4—Metabolism—APRT—kidney cancer	3.18e-06	0.000228	CbGpPWpGaD
Ixabepilone—CYP3A4—Metabolism—GPC3—kidney cancer	2.99e-06	0.000214	CbGpPWpGaD
Ixabepilone—CYP3A4—Metabolism—CA2—kidney cancer	2.91e-06	0.000208	CbGpPWpGaD
Ixabepilone—CYP3A4—Metabolism—ALAD—kidney cancer	2.83e-06	0.000203	CbGpPWpGaD
Ixabepilone—CYP3A4—Metabolism—ST3GAL2—kidney cancer	2.77e-06	0.000198	CbGpPWpGaD
Ixabepilone—CYP3A4—Metabolism—ALDH1A1—kidney cancer	2.7e-06	0.000194	CbGpPWpGaD
Ixabepilone—CYP3A4—Metabolism—PGK1—kidney cancer	2.59e-06	0.000186	CbGpPWpGaD
Ixabepilone—CYP3A4—Metabolism—SLC5A3—kidney cancer	2.59e-06	0.000186	CbGpPWpGaD
Ixabepilone—CYP3A4—Metabolism—LDHB—kidney cancer	2.54e-06	0.000182	CbGpPWpGaD
Ixabepilone—CYP3A4—Metabolism—CA9—kidney cancer	2.2e-06	0.000158	CbGpPWpGaD
Ixabepilone—CYP3A4—Metabolism—CRABP1—kidney cancer	1.87e-06	0.000134	CbGpPWpGaD
Ixabepilone—CYP3A4—Metabolism—ITPR2—kidney cancer	1.74e-06	0.000125	CbGpPWpGaD
Ixabepilone—CYP3A4—Metabolism—ACHE—kidney cancer	1.59e-06	0.000114	CbGpPWpGaD
Ixabepilone—CYP3A4—Metabolism—GSTT1—kidney cancer	1.59e-06	0.000114	CbGpPWpGaD
Ixabepilone—CYP3A4—Metabolism—SCARB1—kidney cancer	1.5e-06	0.000108	CbGpPWpGaD
Ixabepilone—CYP3A4—Metabolism—PTGS1—kidney cancer	1.49e-06	0.000107	CbGpPWpGaD
Ixabepilone—CYP3A4—Metabolism—PSMD7—kidney cancer	1.46e-06	0.000105	CbGpPWpGaD
Ixabepilone—CYP3A4—Metabolism—BCHE—kidney cancer	1.38e-06	9.91e-05	CbGpPWpGaD
Ixabepilone—CYP3A4—Metabolism—SLC5A5—kidney cancer	1.37e-06	9.79e-05	CbGpPWpGaD
Ixabepilone—CYP3A4—Metabolism—SLC2A1—kidney cancer	1.32e-06	9.45e-05	CbGpPWpGaD
Ixabepilone—CYP3A4—Metabolism—GSTP1—kidney cancer	1.1e-06	7.89e-05	CbGpPWpGaD
Ixabepilone—CYP3A4—Metabolism—ABCB1—kidney cancer	1.04e-06	7.46e-05	CbGpPWpGaD
Ixabepilone—CYP3A4—Metabolism—GSTM1—kidney cancer	1.01e-06	7.25e-05	CbGpPWpGaD
Ixabepilone—CYP3A4—Metabolism—CYP1A1—kidney cancer	9.59e-07	6.87e-05	CbGpPWpGaD
Ixabepilone—CYP3A4—Metabolism—POMC—kidney cancer	7.15e-07	5.12e-05	CbGpPWpGaD
Ixabepilone—CYP3A4—Metabolism—PTGS2—kidney cancer	5.7e-07	4.09e-05	CbGpPWpGaD
Ixabepilone—CYP3A4—Metabolism—PTEN—kidney cancer	4.97e-07	3.56e-05	CbGpPWpGaD
Ixabepilone—CYP3A4—Metabolism—PIK3CA—kidney cancer	3.51e-07	2.51e-05	CbGpPWpGaD
